Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)

Clinical trial NCT00080015 · COMPLETED

Trial details

NCT number: NCT00080015
Sponsor: Ipsen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2004-03-12
Primary completion: 2005-02-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.